Flavonoids Active Against Osteosarcoma: A Review of the Molecular Mechanisms Involved

Author(s): Hui Liu, Yutong Gao, Yonghui Dong, Peng Cheng, Anmin Chen, Hui Huang*

Journal Name: Current Pharmaceutical Design

Volume 23 , Issue 13 , 2017

Become EABM
Become Reviewer
Call for Editor


Osteosarcoma is the most frequent primitive malignant bone tumor affecting adolescents and young adults worldwide. The tumor exhibits aggressive growth in the primary site and readily metastasizes to other organs. There has been no significant improvement in the 5-year survival rate since the 1970s and the figure remains at 60–70%. In addition, the side effects of chemotherapeutic drugs and resistance to chemotherapy compromise the effects of treatment for osteosarcoma. In recent years, the development of flavonoids drugs inhibiting carcinogenesis is attracting great interest in the scientific community. Flavonoids are one kind of polyphenolic compounds widely found in vegetables and fruits. Moreover, flavonoids have become popular compounds, exhibiting comprehensive antitumor activities, while being safe and inexpensive. Here, the literature on the benefits afforded by flavonoids in terms of osteosarcoma treatment is reviewed and certain flavonoids and their effects on osteosarcoma are discussed. These compounds can perturb the cell cycle, induce apoptosis, inhibit tumor cell invasion and metastasis, potentiate the actions of chemotherapeutic agents, trigger autophagy, and stimulate antitumor activity in vivo. In summary, we highlight the currently well-accepted flavonoid compounds and detail the molecular mechanisms by which flavonoids may treat osteosarcoma, and thus the flavonoids exhibit great promise as anti-osteosarcoma agents.

Keywords: Flavonoids, osteosarcoma, cell cycle, apoptosis, metastasis, autophagy, antitumor.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Published on: 23 May, 2017
Page: [1993 - 2001]
Pages: 9
DOI: 10.2174/1381612823666170214115718
Price: $65

Article Metrics

PDF: 35